Literature DB >> 19232225

Risk factors for sporadic Campylobacter infection: an all-Ireland case-control study.

K Danis1, M Di Renzi, W O'Neill, B Smyth, P McKeown, B Foley, V Tohani, M Devine.   

Abstract

We report the findings of the first case-control study conducted in both the Republic of Ireland and Northern Ireland to determine risk factors for sporadic Campylobacter infections. A total of 197 cases and 296 case-nominated controls matched for age, were included. Based on Population Attributable Fraction (PAF), the most important risk factors were consuming chicken [adjusted matched (am) OR 6.8; 95%CI 2.1-21.9], consuming lettuce (amOR 3.3; 95%CI 1.5-7.1) and eating in takeaways (amOR=3.1; 95%CI 1.4-6.6). Contact with sheep (amOR=11; 95%CI 1.6-78), peptic ulcer (amOR=19; 95%CI 3.8-93.7), hiatus hernia (amOR=20.3; 95%CI 2.3-183.3), lower bowel problems (amOR=4.5; 95%CI 1.2-16.8) were also independently associated with infection. Mains water supply showed protective effect (amOR=0.2; 95 CI 0.1-0.9). The findings highlight the continued need for consumer food safety education and further control measures throughout the food chain on the island of Ireland.

Entities:  

Mesh:

Year:  2009        PMID: 19232225

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  18 in total

Review 1.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

2.  Molecular evidence for zoonotic transmission of an emergent, highly pathogenic Campylobacter jejuni clone in the United States.

Authors:  Orhan Sahin; Collette Fitzgerald; Steven Stroika; Shaohua Zhao; Rachel J Sippy; Patrick Kwan; Paul J Plummer; Jing Han; Michael J Yaeger; Qijing Zhang
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

Review 3.  The impact of socioeconomic status on foodborne illness in high-income countries: a systematic review.

Authors:  K L Newman; J S Leon; P A Rebolledo; E Scallan
Journal:  Epidemiol Infect       Date:  2015-01-20       Impact factor: 2.451

4.  Epidemiology of Campylobacter jejuni outbreak in a middle school in Incheon, Korea.

Authors:  Jun-Hwan Yu; Na-Yeon Kim; Nam-Gue Cho; Jung-Hee Kim; Young-Ah Kang; Ha-Gyung Lee
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

5.  Geographic determinants of reported human Campylobacter infections in Scotland.

Authors:  Paul R Bessell; Louise Matthews; Alison Smith-Palmer; Ovidiu Rotariu; Norval J C Strachan; Ken J Forbes; John M Cowden; Stuart W J Reid; Giles T Innocent
Journal:  BMC Public Health       Date:  2010-07-15       Impact factor: 3.295

Review 6.  The chronic gastrointestinal consequences associated with campylobacter.

Authors:  Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal:  Curr Gastroenterol Rep       Date:  2012-10

7.  Do patients with recurrent episodes of campylobacteriosis differ from those with a single disease event?

Authors:  Julie Arsenault; André Ravel; Pascal Michel; Olaf Berke; Pierre Gosselin
Journal:  BMC Public Health       Date:  2011-01-12       Impact factor: 3.295

8.  A population-based exposure assessment of risk factors associated with gastrointestinal pathogens: a Campylobacter study.

Authors:  L A MacRitchie; C J Hunter; N J C Strachan
Journal:  Epidemiol Infect       Date:  2012-08-09       Impact factor: 4.434

9.  Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010-2011: A National Prospective Case-Control Study.

Authors:  Emily MacDonald; Richard White; Ricardo Mexia; Tone Bruun; Georg Kapperud; Heidi Lange; Karin Nygård; Line Vold
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

10.  Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England.

Authors:  Clarence C Tam; Craig D Higgins; Keith R Neal; Laura C Rodrigues; Sally E Millership; Sarah J O'Brien
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.